Vivos Therapeutics Inc
(VVOS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,692 | -3,763 | -13,583 | -9,324 | -7,231 |
| Depreciation Amortization | 291 | 146 | 621 | 472 | 323 |
| Accounts receivable | -193 | -324 | 255 | 229 | 130 |
| Accounts payable and accrued liabilities | -117 | 354 | 734 | 118 | -86 |
| Other Working Capital | -757 | 802 | 2,864 | 1,958 | 1,245 |
| Other Operating Activity | 904 | 269 | -2,837 | -2,651 | -779 |
| Operating Cash Flow | $-5,564 | $-2,516 | $-11,946 | $-9,198 | $-6,398 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -211 | -151 | -803 | -638 | -484 |
| Other Investing Activity | 0 | 0 | -50 | -50 | -50 |
| Investing Cash Flow | $-211 | $-151 | $-853 | $-688 | $-534 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 11,441 | 3,941 | 12,000 | 8,000 | 8,000 |
| Other Financing Activity | -406 | -306 | -1,077 | -645 | -645 |
| Financing Cash Flow | $11,035 | $3,635 | $10,923 | $7,355 | $7,355 |
| Beginning Cash Position | 1,643 | 1,643 | 3,519 | 3,519 | 3,519 |
| End Cash Position | 6,903 | 2,611 | 1,643 | 988 | 3,942 |
| Net Cash Flow | $5,260 | $968 | $-1,876 | $-2,531 | $423 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,564 | -2,516 | -11,946 | -9,198 | -6,398 |
| Capital Expenditure | -211 | -151 | -803 | -638 | -484 |
| Free Cash Flow | -5,775 | -2,667 | -12,749 | -9,836 | -6,882 |